Daniel Ferry
Speaker Host
Replay available
Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings Call
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) Q2 2024 earnings conference call, held 2024-08-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Marcio Sousa
President and Chief Executive Officer
Tim Kelly
Chief Financial Officer
Yasmin Rahimi
Analyst, 5% Learning
Jun Lee
Analyst, Truist
Ritu Barrow
Analyst, TD Cowen
Joel Vita
Analyst, Baird
Amit Bhatia
Analyst, Needham
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Praxis Precision Medicines, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.192 Good day. Thank you for standing by. Welcome to the Practice Physician Medicine second 00:00:05.192 -- 00:00:08.353 quarter 2024 Corporate Update Conference Call. 00:00:08.353 -- 00:00:11.495 At this time, all participants are in a listen-only mode. 00:00:11.495 -- 00:00:14.716 After the speaker's presentation, there will be a question and answer session. 00:00:14.716 -- 00:00:19.899 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:19.899 -- 00:00:23.441 You will then hear an automatic message advising your hand is raised. 00:00:23.441 -- 00:00:26.162 Please note that today's conference is being recorded. 00:00:26.162 -- 00:00:29.024 I will now hand the conference over to your speaker host, Daniel Ferry. 00:00:29.024 -- 00:00:31.404 Please go ahead. 00:00:33.456 -- 00:00:39.458 Good morning, and welcome to Praxis Precision Medicine's second quarter 2024 00:00:39.458 -- 00:00:43.420 financial results and business update conference call. 00:00:43.420 -- 00:00:48.702 This call is being webcast live and can be accessed on the investor section 00:00:48.702 -- 00:00:52.963 of Praxis' website at www.praxismedicines.com. 00:00:55.065 -- 00:00:57.546 This call is also being recorded. 00:00:57.546 -- 00:01:01.343 Please note that remarks made during this call may contain forward-looking statements 00:01:01.343 -- 00:01:04.965 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:01:04.965 -- 00:01:06.965 These 00:01:07.226 -- 00:01:11.869 may include statements about the company's future expectations and plans, 00:01:11.869 -- 00:01:14.991 clinical development timelines, and financial projections. 00:01:14.991 -- 00:01:19.633 While these forward-looking statements represe...